[6-(4-hydroxy-5-propan-2-yl-2-sulfanylidene-1H-imidazol-3-yl)-3-pyridinyl] 4-pyridin-2-ylpiperazine-1-carboxylate

C21H24N6O3S — CID 90791213

IUPAC[6-(4-hydroxy-5-propan-2-yl-2-sulfanylidene-1H-imidazol-3-yl)-3-pyridinyl] 4-pyridin-2-ylpiperazine-1-carboxylate
SMILESCC(C)c1[nH]c(=S)n(-c2ccc(OC(=O)N3CCN(c4ccccn4)CC3)cn2)c1O
InChIInChI=1S/C21H24N6O3S/c1-14(2)18-19(28)27(20(31)24-18)17-7-6-15(13-23-17)30-21(29)26-11-9-25(10-12-26)16-5-3-4-8-22-16/h3-8,13-14,28H,9-12H2,1-2H3,(H,24,31)
InChIKeyRGNHUHYQZLZNDV-UHFFFAOYSA-N
MW440.53 g/mol
LogP3.47
Rot. Bonds4

About [6-(4-hydroxy-5-propan-2-yl-2-sulfanylidene-1H-imidazol-3-yl)-3-pyridinyl] 4-pyridin-2-ylpiperazine-1-carboxylate

[6-(4-hydroxy-5-propan-2-yl-2-sulfanylidene-1H-imidazol-3-yl)-3-pyridinyl] 4-pyridin-2-ylpiperazine-1-carboxylate (PubChem CID 90791213) has the molecular formula C21H24N6O3S and a molecular weight of 440.53 g/mol. Its IUPAC name is [6-(4-hydroxy-5-propan-2-yl-2-sulfanylidene-1H-imidazol-3-yl)-3-pyridinyl] 4-pyridin-2-ylpiperazine-1-carboxylate.

Molecular Properties

Compound Name[6-(4-hydroxy-5-propan-2-yl-2-sulfanylidene-1H-imidazol-3-yl)-3-pyridinyl] 4-pyridin-2-ylpiperazine-1-carboxylate
PubChem CID90791213
Molecular FormulaC21H24N6O3S
Molecular Weight440.53 g/mol
Exact Mass440.16
IUPAC Name[6-(4-hydroxy-5-propan-2-yl-2-sulfanylidene-1H-imidazol-3-yl)-3-pyridinyl] 4-pyridin-2-ylpiperazine-1-carboxylate
SMILESCC(C)c1[nH]c(=S)n(-c2ccc(OC(=O)N3CCN(c4ccccn4)CC3)cn2)c1O
InChIInChI=1S/C21H24N6O3S/c1-14(2)18-19(28)27(20(31)24-18)17-7-6-15(13-23-17)30-21(29)26-11-9-25(10-12-26)16-5-3-4-8-22-16/h3-8,13-14,28H,9-12H2,1-2H3,(H,24,31)
InChIKeyRGNHUHYQZLZNDV-UHFFFAOYSA-N
XLogP3.47
TPSA99.51 Ų
H-Bond Donors2
H-Bond Acceptors8
Rotatable Bonds4
Heavy Atoms31
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500440.53
LogP ≤ 53.47
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Thiocarbonyl_group', 'substructure': 'N/A'}

Analyze [6-(4-hydroxy-5-propan-2-yl-2-sulfanylidene-1H-imidazol-3-yl)-3-pyridinyl] 4-pyridin-2-ylpiperazine-1-carboxylate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of [6-(4-hydroxy-5-propan-2-yl-2-sulfanylidene-1H-imidazol-3-yl)-3-pyridinyl] 4-pyridin-2-ylpiperazine-1-carboxylate?
The IUPAC name of [6-(4-hydroxy-5-propan-2-yl-2-sulfanylidene-1H-imidazol-3-yl)-3-pyridinyl] 4-pyridin-2-ylpiperazine-1-carboxylate (CID 90791213) is [6-(4-hydroxy-5-propan-2-yl-2-sulfanylidene-1H-imidazol-3-yl)-3-pyridinyl] 4-pyridin-2-ylpiperazine-1-carboxylate.
What is the SMILES notation for [6-(4-hydroxy-5-propan-2-yl-2-sulfanylidene-1H-imidazol-3-yl)-3-pyridinyl] 4-pyridin-2-ylpiperazine-1-carboxylate?
The canonical SMILES for [6-(4-hydroxy-5-propan-2-yl-2-sulfanylidene-1H-imidazol-3-yl)-3-pyridinyl] 4-pyridin-2-ylpiperazine-1-carboxylate is CC(C)c1[nH]c(=S)n(-c2ccc(OC(=O)N3CCN(c4ccccn4)CC3)cn2)c1O.
What is the InChIKey of [6-(4-hydroxy-5-propan-2-yl-2-sulfanylidene-1H-imidazol-3-yl)-3-pyridinyl] 4-pyridin-2-ylpiperazine-1-carboxylate?
The InChIKey is RGNHUHYQZLZNDV-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H24N6O3S/c1-14(2)18-19(28)27(20(31)24-18)17-7-6-15(13-23-17)30-21(29)26-11-9-25(10-12-26)16-5-3-4-8-22-16/h3-8,13-14,28H,9-12H2,1-2H3,(H,24,31).
What are the key properties of [6-(4-hydroxy-5-propan-2-yl-2-sulfanylidene-1H-imidazol-3-yl)-3-pyridinyl] 4-pyridin-2-ylpiperazine-1-carboxylate?
[6-(4-hydroxy-5-propan-2-yl-2-sulfanylidene-1H-imidazol-3-yl)-3-pyridinyl] 4-pyridin-2-ylpiperazine-1-carboxylate has a molecular weight of 440.53 g/mol, XLogP of 3.47, 4 rotatable bonds, 2 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for [6-(4-hydroxy-5-propan-2-yl-2-sulfanylidene-1H-imidazol-3-yl)-3-pyridinyl] 4-pyridin-2-ylpiperazine-1-carboxylate is sourced from PubChem (CID 90791213), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).